Theragnostics, which is developing radiopharmaceuticals for cancer treatment, announces that the company will be attending the Jefferies 2020 Virtual London Healthcare Conference taking place November 17-19, 2020.
Chief Executive Officer, Greg Mullen, PhD, FRSC and Chief Operating Officer, Gareth Smith will be meeting with individual investors and participating in the breakout events.
For media and investor enquiries please contact Optimum Strategic Communications
Mary Clark, Shabnam Bashir, Manel Mateus
theragnostics@optimumcomms.com
Tel: +44(0)20-950-9144
